ESC 365 - SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

Back

Open Access

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

Session: SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor S. Solomon (Boston, US)

Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

5 more presentations in this session

SGLT2 inhibitors across the spectrum of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Slides

Video

Practical considerations for treating HF with mildly reduced and preserved EF.

Speaker: Professor C. Lam (Singapore, SG)

Access

Slides

Video

Implementing best practices across the spectrum of heart failure.

Speaker: Doctor M. Vaduganathan (Boston, US)

Access

Slides

Video

Summary.

Access

Slides

Video

Discussion.

Access

Video

Access the full session

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Speakers: Professor S. Solomon, Professor J. McMurray, Professor C. Lam, Doctor M. Vaduganathan

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources